H. L. McLeod - Concepedia

Author

H. L. McLeod

University of Aberdeen

Also Known As

B Dieckgraefe, H L McLeod, H MCLEOD, H McLeod, H Mcleod, H. L. McLeod, H. McLeod, H.L McLeod, H.L. McLeod, HL McLeod

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

University of Aberdeen Washington University in St. Louis National Cancer Institute St. Jude Children's Research Hospital Mayo Clinic

About

H. L. McLeod is an author at University of Aberdeen specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	1K
2	Health Sciences	3	3	302
3	Public Health	2	2	75
4	Biochemistry	1	1	104
5	Cell Biology	1	1	40

H. L. McLeod

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations Elaina Collie–Duguid, Pritchard, Powrie, Pharmacogenetics	1999	366
A double-blind, placebo-controlled, randomized phase III trial of gemcitabine (G) plus bevacizumab (B) versus gemcitabine plus placebo (P) in patients (pts) with advanced pancreatic cancer (PC): A preliminary analysis of Cancer and Leukemia Group B (CALGB Hedy L. Kindler, Donna Niedzwiecki, Donna Hollis, Journal of Clinical Oncology PharmacotherapyTreatment VerificationRadiation MedicineOncologyPancreatic Cancer	2007	237
Known variant DPYD alleles do not explain DPD deficiency in cancer patients Elaina Collie–Duguid, M C Etienne, G. Milano, Pharmacogenetics	2000	180
Irinotecan-induced Diarrhea: Functional Significance of the Polymorphic ABCC2 Transporter Protein F A de Jong, T J Scott-Horton, Deanna L. Kroetz, Clinical Pharmacology & Therapeutics	2006	171
Variants in the SLCO1B3 Gene: Interethnic Distribution and Association with Paclitaxel Pharmacokinetics Nicola F. Smith, Steven G. E. Marsh, T J Scott-Horton, Clinical Pharmacology & Therapeutics	2006	162
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Rasburicase Therapy in the Context of G6PD Deficiency Genotype Mary V. Relling, Ellen M. McDonagh, Tai‐Tsung Chang, Clinical Pharmacology & Therapeutics	2014	140
Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black Americans. William E. Evans, Mary V. Relling, Atiqur Rahman, Journal of Clinical Investigation Metabolic SyndromeMendelian DisorderGenetic DisorderMedicineGenetics	1993	110
Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours H. L. McLeod, J Sludden, G I Murray, British Journal of Cancer Tumor BiologyBiochemistryOncogenic AgentMedicineColorectal Cancer	1998	104
Nomenclature for human DPYD alleles H. L. McLeod, Elaina Collie–Duguid, P. Vreken, Pharmacogenetics GeneticsHuman PolymorphismMolecular GeneticsGenomicsHuman Dpyd Alleles	1998	96
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer S A Ridge, J Sludden, Xiaoxiong Wei, British Journal of Cancer OncologyMedicineColorectal CancerPharmacologyCancer Research	1998	93

Page 1